Proximal Myopathy induced by 5-HT-Imipramine simulates Duchenne Dystrophy

No abstract is available for this paper.

• Publication year

  1974

• Venue

  Nature

• Publication date

  1974-01-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/247103B0PMID 4809132
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serotonin and platelet function in Duchenne muscular dystrophy.

  1973cited by this paper
• CHAPTER 13 – The Transport of Biogenic Amines

  1972cited by this paper
• Duchenne Muscular Dystrophy: Functional Ischemia Reproduces Its Characteristic Lesions

  1971cited by this paper
• Experimental myopathy after microarterial embolization; comparison with childhood x-linked pseudohypertrophic muscular dystrophy.

  1970cited by this paper
• Neurological Diagnostic Techniques.

  1967cited by this paper

• Translational Medicine: Evolution, Fulfillment, and Belief in Gene Therapy

  2020cites this paper
• Duchenne muscular dystrophy: an historical treatment review.

  2019cites this paper
• Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.

  2014cites this paper
• Monoamine oxidase inhibition prevents mitochondrial dysfunction and apoptosis in myoblasts from patients with collagen VI myopathies

  2014cites this paper
• Oxidative stress in muscular dystrophy: from generic evidence to specific sources and targets

  2014cites this paper
• Pre-clinical study of 21 approved drugs in the mdx mouse.

  2011cites this paper
• Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin

  2010cites this paper
• Chronic Hypoxia Impairs Muscle Function in the Drosophila Model of Duchenne's Muscular Dystrophy (DMD)

  2010cites this paper
• Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy.

  2009cites this paper
• Serotonin Metabolism in the Normal and Failing Hamster Heart

  2005cites this paper
• The pattern of urinary catecholamines and their metabolites in Duchenne myopathy, in relation to disease evolution

  2005cites this paper
• Mechanismsof CellularEnzyme Release. I. Alterationin Membrane Fluidityand Permeability

  2004cites this paper
• Experimental serotonin myopathy as an animal model of muscle degeneration and regeneration in muscular dystrophy

  2004cites this paper
• Neuromuscular diseases and disorders of the alimentary system

  2002cites this paper
• Polyamine biosynthetic decarboxylases in muscles of rats with different experimental myopathies.

  1989cites this paper
• Autoimmune pathogenesis of paraneoplastic neurological syndromes.

  1987cites this paper
• Vascular endothelial cell injury and platelet embolism in Duchenne muscular dystrophy at the preclinical stage.

  1987cites this paper
• Effects of noradrenaline, serotonin, and selected antagonists on the vascular smooth muscle of normal and dystrophic chickens.

  1986cites this paper
• Serotonin-induced contractile and structural changes in fast and slow skeletal muscles in mice.

  1985cites this paper
• SOME HISTOCHEMICAL OBSERVATIONS ON INVASIVE CELLS IN A MYOPATHY INDUCED IN RATS WITH 5–HYDROXYTRYPTAMINE

  1984cites this paper
• Paraneoplastic syndromes that involve the nervous system.

  1983cites this paper
• PREVENTION OF HALOTHANE-INDUCED MALIGNANT HYPERTHERMIA IN STRESS-SUSCEPTIBLE PIGS WITH 5-HT2 ANTAGONISTS

  1982cites this paper
• Release of creatine kinase and lactate dehydrogenase from frog skeletal muscles treated with imipramine.

  1982cites this paper
• The influence of ketanserin, a new S2 receptor antagonist on experimentally induced skeletal muscle myopathy in the rat

  1981cites this paper
• Animal models: what is their relevance to the pathogenesis of human muscular dystrophy?

  1980cites this paper
• Lipolysis and cyclic AMP response to isoproterenol in diaphragms from control and dystrophic mice.

  1980cites this paper
• PHARMACOLOGIC THERAPY OF DYSTROPHY IN MAN AND ANIMALS *

  1979cites this paper
• Experimental ischemic myopathy. Effects of aortic ligation and serotonin.

  1979cites this paper
• Pharmocologic therapy of dystrophy in man and animals.

  1979cites this paper
• Cerebral gangliosides in the treatment of peripheral neuronal diseases.

  1979cites this paper
• Skeletal muscle morphology of depressed patients after medication.

  1979cites this paper
• The neuromuscular and vascular hypotheses of muscular dystrophy: a possible link via adenine nucleotides and phosphate.

  1979cites this paper
• Delayed functional disability in dystrophic chickens receiving chemotherapy

  1979cites this paper
• Serotonin Metabolism in the Normal and Failing Hamster Heart

  1979cites this paper
• Therapeutic effect of 5-hydroxytryptamine antagonists on inherited muscular dystrophy in the chicken and hamster [proceedings].

  1978cites this paper
• Absorption and distribution of sodium [2-14C]barbital in tissues of normal and dystrophic mice.

  1978cites this paper
• End-plate voltage noise during prolonged application of acetylcholine in cat tenuissimus muscle [proceedings].

  1978cites this paper
• The muscular dystrophies and related disorders. 1. The muscular dystrophies.

  1978cites this paper
• Serotonin accumulation by skeletal muscle.

  1977cites this paper
• Blood vessel structure in Duchenne muscular dystrophy. I. Light and electron microscopic observations in resting muscle

  1977cites this paper
• The roles of prostaglandins and calcium accumulation in muscular dystrophy.

  1977cites this paper
• Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy.

  1977cites this paper
• Effects of serotonin antagonists on the development of inherited muscular dystrophy in the chicken.

  1977cites this paper
• Mechanisms of cellular enzyme release. I. Alteration in membrane fluidity and permeability.

  1977cites this paper
• The pharmacology of experimental myopathies.

  1977cites this paper
• Muscular dystrophies of childhood.

  1977cites this paper
• Experimental serotonin myopathy

  1977cites this paper
• Erythrocyte membrane abnormality in muscular dystrophy.

  1977cites this paper
• Abnormal Levels of Urinary Catecholamines in Dystrophic Mice and Hamsters

  1976cites this paper
• Inhibition of actomyosin ATPase by high concentrations of 5-hydroxytryptamine. Possible basis of lesion in 5HT-induced experimental myopathy.

  1976cites this paper
• Sarcolemmal membrane changes related to enzyme release in the imipramine/serotonin experimental animal model.

  1976cites this paper
• Skeletal muscle necrosis following membrane-active drugs plus serotonin.

  1976cites this paper
• Serum creatine phosphokinase in schizophrenia.

  1976cites this paper
• Neuromuscular dysfunction in schizophrenia.

  1976cites this paper
• Failure of a Serotonin Inhibitor to Effect Nocturnal GH and Prolactin Secretion in Patients with Duchenne Muscular Dystrophy

  1976cites this paper
• Significance of creatine phosphokinase isoenzymes in Duchenne dystrophy

  1976cites this paper
• Pathogenesis of muscular dystrophies.

  1976cites this paper
• Muscular dystrophy of mink: a new animal model.

  1976cites this paper
• Retardation of symptoms of dystrophy in genetically dystrophic chickens by chemotherapy.

  1976cites this paper
• Imipramine‐serotonin induced myopathy

  1976cites this paper
• Increased axoplasmic flow associated with pargyline under conditions which induce a myopathy

  1975cites this paper
• Muscular Disorders

  1975cites this paper
• Drugs blocking the muscle-damaging effects of 5-HT and noradrenaline in aorta-ligatured rats

  1975cites this paper
• Interaction of glyoxal and methylglyoxal with biogenic amines.

  1975cites this paper
• Pathogenesis of muscular dystrophies. Sympathetic neurovascular components.

  1975cites this paper
• Carcinoid myopathy. Serotonin-induced muscle weakness in man?

  1975cites this paper
• Axoplasmic flow of protein in the sciatic nerve of mice with experimentally induced myopathy.

  1975cites this paper
• Serum Creatine Phosphokinase Activity in Acute Psychosis

  1973cites this paper